Chengmeng Jin

642 total citations
13 papers, 463 citations indexed

About

Chengmeng Jin is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Chengmeng Jin has authored 13 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Chengmeng Jin's work include Cancer, Hypoxia, and Metabolism (4 papers), ATP Synthase and ATPases Research (2 papers) and Epigenetics and DNA Methylation (2 papers). Chengmeng Jin is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), ATP Synthase and ATPases Research (2 papers) and Epigenetics and DNA Methylation (2 papers). Chengmeng Jin collaborates with scholars based in China, United States and Germany. Chengmeng Jin's co-authors include Xun Hu, Biaoyang Lin, Xu Han, Xiaoyan Lou, Li‐Hua Cheng, Wei Yu, Hao Wu, Yuqi Wang, Minfeng Ying and Qiuping Ding and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.

In The Last Decade

Chengmeng Jin

12 papers receiving 455 citations

Peers

Chengmeng Jin
Lucie Ahn United States
Chengmeng Jin
Citations per year, relative to Chengmeng Jin Chengmeng Jin (= 1×) peers Lucie Ahn

Countries citing papers authored by Chengmeng Jin

Since Specialization
Citations

This map shows the geographic impact of Chengmeng Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengmeng Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengmeng Jin more than expected).

Fields of papers citing papers by Chengmeng Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengmeng Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengmeng Jin. The network helps show where Chengmeng Jin may publish in the future.

Co-authorship network of co-authors of Chengmeng Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Chengmeng Jin. A scholar is included among the top collaborators of Chengmeng Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengmeng Jin. Chengmeng Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Jin, Chengmeng, Wei Hu, Yuqi Wang, et al.. (2024). Deciphering the interaction between PKM2 and the built-in thermodynamic properties of the glycolytic pathway in cancer cells. Journal of Biological Chemistry. 300(9). 107648–107648.
2.
Guo, Yifei, Jiajia Han, Yongmei Zhang, et al.. (2023). End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation. Frontiers in Cellular and Infection Microbiology. 13. 1120300–1120300. 4 indexed citations
3.
Jin, Chengmeng, et al.. (2022). Alkalization of cellular pH leads to cancer cell death by disrupting autophagy and mitochondrial function. Oncogene. 41(31). 3886–3897. 21 indexed citations
4.
Wu, Hao, Yuqi Wang, Minfeng Ying, et al.. (2021). Lactate dehydrogenases amplify reactive oxygen species in cancer cells in response to oxidative stimuli. Signal Transduction and Targeted Therapy. 6(1). 242–242. 72 indexed citations
5.
Jin, Chengmeng, et al.. (2021). Determining the quantitative relationship between glycolysis and GAPDH in cancer cells exhibiting the Warburg effect. Journal of Biological Chemistry. 296. 100369–100369. 28 indexed citations
6.
Jin, Chengmeng, et al.. (2020). Perturbation of phosphoglycerate kinase 1 (PGK1) only marginally affects glycolysis in cancer cells. Journal of Biological Chemistry. 295(19). 6425–6446. 23 indexed citations
7.
Wang, Rong, Chengmeng Jin, & Xun Hu. (2017). Evidence of drug-response heterogeneity rapidly generated from a single cancer cell. Oncotarget. 8(25). 41113–41124. 11 indexed citations
8.
Jin, Chengmeng, Dasong Hua, Fan Zhou, et al.. (2014). Next Generation Sequencing Analysis of miRNAs: MiR-127-3p Inhibits Glioblastoma Proliferation and Activates TGF-β Signaling by Targeting SKI. OMICS A Journal of Integrative Biology. 18(3). 196–206. 42 indexed citations
9.
Liu, Jie, Jianbo Sun, Lisha Li, et al.. (2014). Next-Generation Sequencing of Colorectal Cancers in Chinese: Identification of a Recurrent Frame-Shift and Gain-of-Function Indel Mutation in the TFDP1 Gene. OMICS A Journal of Integrative Biology. 18(10). 625–635. 12 indexed citations
10.
Jin, Chengmeng, Wei Yu, Xiaoyan Lou, et al.. (2013). UCHL1 Is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance. Journal of Cancer. 4(8). 662–670. 61 indexed citations
11.
Lou, Xiaoyan, Xu Han, Chengmeng Jin, et al.. (2013). SOX2 Targets Fibronectin 1 to Promote Cell Migration and Invasion in Ovarian Cancer: New Molecular Leads for Therapeutic Intervention. OMICS A Journal of Integrative Biology. 17(10). 510–518. 77 indexed citations
12.
Yu, Wei, Chengmeng Jin, Xiaoyan Lou, et al.. (2011). Global Analysis of DNA Methylation by Methyl-Capture Sequencing Reveals Epigenetic Control of Cisplatin Resistance in Ovarian Cancer Cell. PLoS ONE. 6(12). e29450–e29450. 54 indexed citations
13.
Cheng, Li‐Hua, et al.. (2011). Developing a Highly Stable PLGA-mPEG Nanoparticle Loaded with Cisplatin for Chemotherapy of Ovarian Cancer. PLoS ONE. 6(9). e25433–e25433. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026